NPI: 1538414941 · MANKATO, MN 56001 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 07/23/2012
Authorized official WINSTEL, JOHN controls 20+ related entities in our dataset. Read more
| Authorized Official | WINSTEL, JOHN (CHIEF ACCOUNTING OFFICER) |
| NPI Enumeration Date | 07/23/2012 |
Other providers sharing the same authorized official: WINSTEL, JOHN
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 10,068 | $185K |
| 2019 | 12,452 | $432K |
| 2020 | 12,307 | $467K |
| 2021 | 12,547 | $513K |
| 2022 | 7,728 | $408K |
| 2023 | 2,132 | $339K |
| 2024 | 352 | $69K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 17,473 | 1,236 | $2.34M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 19,868 | 1,071 | $41K |
| A4657 | Syringe, with or without needle, each | 7,720 | 1,227 | $24K |
| J1270 | Injection, doxercalciferol, 1 mcg | 10,768 | 832 | $3K |
| J1756 | Injection, iron sucrose, 1 mg | 1,099 | 286 | $2K |
| 90674 | 27 | 25 | $321.14 | |
| G0008 | Administration of influenza virus vaccine | 30 | 29 | $307.62 |
| 83970 | 36 | 26 | $0.00 | |
| 85048 | 97 | 73 | $0.00 | |
| 85041 | 99 | 74 | $0.00 | |
| 83540 | 111 | 87 | $0.00 | |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 19 | 12 | $0.00 |
| 82728 | 111 | 87 | $0.00 | |
| 83550 | 111 | 87 | $0.00 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 17 | 12 | $0.00 |